Clinical Trials
2 trialsNCT03761914 2024-11-19
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
Sellas Life Sciences Group
Phase 1/2 Completed
NCT00640861 2018-10-31
Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed